Literature DB >> 7138767

In-vitro resistance of cloned human glioma cells to natural killer activity of allogeneic peripheral lymphocytes.

K S Zänker, A Trappe, G Blümel.   

Abstract

Cells from an established culture of a human astrocytoma were incubated with normal allogeneic peripheral lymphocytes (PBL) in order to study the natural killer (NK) sensitivity of the in vitro propagated cell line. A proportion of cells in culture formed halos, into which lymphocytes did not penetrate. These cells were successfully cloned and showed a decreased susceptibility to NK cytolysis compared with the parent line. Both cell lines could be transplanted into athymic nude mice. The cloned NK-resistant cells underwent a frequent spontaneous regression in nu/nu mice, despite the fact that when used as targets for nu/nu NK cells in vitro they were only moderately susceptible. Phase-contrast microscopy of the mass-cultured cells co-cultivated with lymphocytes suggested that their morphology and ability to form inpenetrable translucent halos might influence their susceptibility to NK lysis. Experiments performed on this assumption revealed that quiescent and halo forming tumour cells were not the primary targets for NK lysis. Cells in mass culture, although tumorigenic, were thus heterogeneous in respect of susceptibility to NK attack. These findings might be relevant to the mechanism of immune escape and tumour heterogeneity in respect of spontaneous cell-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138767      PMCID: PMC2011203          DOI: 10.1038/bjc.1982.246

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Susceptibility of tumor cells in different phases of the mitotic cycle to the effect of immune lymphocytes.

Authors:  N V Leneva; G J Svet-Moldavsky
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

2.  Relationship between cell-mediated and humoral immune attack on tumor cells. I. Drug and hormone effects on susceptibility to killing and macromolecular synthesis.

Authors:  S I Schlager
Journal:  Cell Immunol       Date:  1981-03-01       Impact factor: 4.868

Review 3.  Interaction of cytotoxic T lymphocytes and target cells.

Authors:  G Berke
Journal:  Prog Allergy       Date:  1980

4.  Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.

Authors:  S I Schlager; S H Ohanian
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

5.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

6.  Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay.

Authors:  P L Kornblith; L A Pollock; H B Coakham; E A Quindlen; W C Wood
Journal:  J Neurosurg       Date:  1979-07       Impact factor: 5.115

7.  Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.

Authors:  A Mantovani; P Allavena; C Sessa; G Bolis; C Mangioni
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

8.  The influence of various chemicals on the surface structure and the antigenicity of syngeneic glioma cells.

Authors:  K S Zänker; D Stavrou; M Hultén; T Bilzer
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

9.  Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.

Authors:  K H McCormick; B C Giovanella; G Klein; K Nilsson; J S Stehlin
Journal:  Int J Cancer       Date:  1981-10-15       Impact factor: 7.396

10.  Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes.

Authors:  K Bosslet; V Schirrmacher
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  3 in total

1.  Effect of hyaluronidase on the pharmacokinetics of free and total platinum species after intra-arterial Cisplatin in refractory patients with colorectal liver metastases.

Authors:  D Civalleri; M Esposito; F De Cain; F Decian; N Balletto; G Mondini; L Gogioso; M Viale; M O Vannozzi
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

2.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.

Authors:  K Beckenlehner; S Bannke; T Spruss; G Bernhardt; H Schönenberg; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.